{"id":1239339,"title":"DSEN Abstract: Crizotinib and Incidence of Death: A Systematic Review and Network Meta-analysis of ALK Inhibitors for Non-small Cell Lung Cancer - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-06","captureTimestamp":"2026-03-06T19:24:36.113000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/54496.html?wbdisable=true","snippet":"DSEN Abstract Crizotinib and Incidence of Death: A Systematic Review and Network Meta-analysis of ALK Inhibitors for Non-small Cell Lung Cancer Summary We observed that all ALK inhibitors improved progression-free survival relative to chemotherapy, and that alectinib and…","rawSnapshotUrl":"/api/snapshots/raw/1239339","browseUrl":"https://replay.healtharchive.ca/job-8/20260306192436/https://cihr-irsc.gc.ca/e/54496.html?wbdisable=true#ha_snapshot=1239339","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}